Last updated 2026-08-29
- Raised $817k Seed Extension led by eHealth Ventures, Jul 2023
- Raised Seed round led by eHealth Ventures, 2020
Total raised
$817K
Stage
—
Founded
2020
Headcount
1-10
HQ
Tel Aviv, Israel
Sector
Biotechnology
Website ↗Registrar ID: 516274115 (ToDx Ltd.)
About
ToDx is developing a lab-quality molecular diagnostic solution that addresses gaps in healthcare access by providing rapid, reliable, and accessible testing at the point of need, whether in clinics or at home. Their technology aims to improve detection, speed up care, and support better outcomes. The company's single-use molecular diagnostic kit initially focuses on detecting Chlamydia, Gonorrhea, and Trichomonas within minutes, requiring only a smartphone for result interpretation. ToDx plans to expand its technology for additional applications such as High-risk HPV, respiratory infections, UTIs, and broader syndromic panels.
Funding history · 2 rounds · $817K total
2 events/rounds · $817K Total Funding: $817K in Private Equity
Jul 2023
Seed Extension
$817K
pitchbook.com
2020
Seed
Undisclosed
unknown
Offices
Tel Aviv, Israel · HQ / main office
Q&A
- What is ToDx Ltd.'s primary focus?
- ToDx Ltd. is developing an at-home PCR diagnostic platform for rapid, reliable, and accessible testing at the point of need, primarily focusing on medical diagnostics.
- When was ToDx Ltd. founded?
- ToDx Ltd. was founded in 2020.
- Where is ToDx Ltd. headquartered?
- ToDx Ltd. is headquartered in Tel Aviv, Israel.
- Who are the founders of ToDx Ltd.?
- The founders of ToDx Ltd. are Noam Kedem Mamet, who serves as CEO, and Gil Harari, who serves as CTO.
- What specific conditions does ToDx Ltd.'s initial diagnostic kit target?
- ToDx Ltd.'s initial single-use molecular diagnostic kit focuses on detecting Chlamydia, Gonorrhea, and Trichomonas.
- What technology does ToDx Ltd. utilize for result interpretation?
- ToDx Ltd.'s technology requires only a smartphone for result interpretation of its diagnostic tests.
- What are ToDx Ltd.'s plans for expanding its technology?
- ToDx Ltd. plans to expand its technology for additional applications such as High-risk HPV, respiratory infections, UTIs, and broader syndromic panels.
- What are the core technologies behind ToDx Ltd.'s solutions?
- ToDx Ltd.'s core technologies include molecular diagnostics, point-of-care and at-home testing, STI diagnostics, assay development for oligonucleotide markers, and smartphone-based diagnostic readout.
Team · 2
Noam Kedem Mamet
Founder · Founder, CEO
Gil Harari
Founder · Founder, CTO
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | todxathome.com |
|---|
Identifiers & details
| Founded | 2020 |
|---|
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | todxathome.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516274115 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2020-11-01 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 6 — annual_report (3), violation (1), people (2) |
| Registered address | קויפמן יחזקאל 2 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-07-15 | דו~ח שנתי-עדכון מען דיגיטלי |
| 2026-07-15 | דו~ח שנתי-הסרת בעל תפקיד |
| 2026-07-15 | עדכון הפרה |
| 2026-07-15 | דו~ח שנתי-עדכון כתובת |
| 2026-02-11 | עדכון דירקטורים-הוספת דירקטור |
| 2026-02-11 | עדכון דירקטורים-הסרת דירקטור |